ClinStorage has established itself as a trusted partner to pharmaceutical and biotechnology companies by providing secure, regulatory-compliant storage and handling of clinical trial materials. The transaction provides ClinStorage with growth capital and sector-focused ownership to support continued investments in infrastructure, capacity, and service capabilities - while maintaining the quality, compliance, and reliability that define the company’s offering.

Jonas Brambeck brings more than 25 years of experience in life science investing, company building, and strategic transactions. As Industry Advisor, Jonas will support Rubicon in investment evaluation, strategic development of portfolio companies, and engagement with key stakeholders across the Nordic life science ecosystem.

​Through this investment, Rubicon will become the largest shareholder in PeptiSystems following completion of the transaction. The partnership reflects Rubicon’s strategy of supporting high-quality Nordic life science platforms with strong technology foundations, scalable business models, and global market potential.